MALAT1 was highly expressed in exhausted CD8+ T cells (Fig. 8A) and was reported to be linked to breast cancer, pancreatic cancer, prostate cancer, glioma, and leukemia.49 Here, MALAT1 is linked to prostate carcinoma.